KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $11.5 million.

  • Globus Medical's Share-based Compensation fell 551.14% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.3 million, marking a year-over-year decrease of 815.11%. This contributed to the annual value of $54.2 million for FY2024, which is 274.73% up from last year.
  • Per Globus Medical's latest filing, its Share-based Compensation stood at $11.5 million for Q3 2025, which was down 551.14% from $13.6 million recorded in Q2 2025.
  • Globus Medical's 5-year Share-based Compensation high stood at $22.8 million for Q3 2023, and its period low was $7.5 million during Q3 2021.
  • For the 5-year period, Globus Medical's Share-based Compensation averaged around $11.0 million, with its median value being $9.0 million (2023).
  • In the last 5 years, Globus Medical's Share-based Compensation surged by 17369.5% in 2023 and then tumbled by 4633.71% in 2024.
  • Over the past 5 years, Globus Medical's Share-based Compensation (Quarter) stood at $7.8 million in 2021, then increased by 8.99% to $8.5 million in 2022, then soared by 46.29% to $12.4 million in 2023, then dropped by 4.32% to $11.9 million in 2024, then fell by 3.1% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $13.6 million for Q2 2025, and $13.2 million during Q1 2025.